imiquimod has been researched along with Genital Warts in 225 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (10.22) | 18.2507 |
2000's | 120 (53.33) | 29.6817 |
2010's | 65 (28.89) | 24.3611 |
2020's | 17 (7.56) | 2.80 |
Authors | Studies |
---|---|
Bhandari, M; Bhargava, A; Khullar, G; Khunger, N; Mittal, S; Yadav, AK | 1 |
Ciccarese, G; Drago, F; Parodi, A | 1 |
Bhari, N; Gupta, S; Sindhuja, T | 1 |
De la Torre Gomar, FJ; Gimeno Castillo, J; Saenz Aguirre, A | 1 |
Christman, MA; McKinzie, AH | 1 |
Ljubojević Hadžavdić, S; Skerlev, M; Tomić, L | 1 |
Bastida, C; Blanco, JL; Cranston, RD; Fuertes, I; Lopez-Cabezas, C; Mallolas, J; Ordi, J; Rodríguez-Carunchio, L | 1 |
Chang, SE; Choi, JH; Jung, CJ; Jung, JM; Lee, MW; Lee, WJ; Won, CH | 1 |
Barton, S; Edwards, S; O'Mahony, C; Wakefield, V | 1 |
Egawa, G; Egawa, K; Egawa, N; Honda, Y; Ihn, H; Kawano, Y; Noguchi, H | 1 |
Cavada Ch, G; Huneeus V, A; Massoc P, A; Rivera M, F; Schilling R, A | 1 |
Assil, S; Burggraaf, J; Buters, TP; Feiss, G; Florencia, E; Klaassen, ES; Moerland, M; Niemeyer-van der Kolk, T; Prens, EP; Rijsbergen, M; Rissmann, R; van Doorn, MBA | 1 |
Bai, M; Chen, Z; Feng, C; Li, W; Si, L; Wang, X; Zhang, H | 1 |
Blontzos, N; Douligeris, A; Fotiou, A; Iavazzo, C; Karavioti, E; Prodromidou, A; Psomiadou, V; Vorgias, G | 1 |
Carnevale, C; D'Argenio, P; Diociaiuti, A; El Hachem, M; Giancristoforo, S; Lucchetti, MC; Rotunno, R; Tchidjou, HK | 1 |
Marino, F | 1 |
Bennett, K; Caverly, E; Copas, AJ; Doré, CJ; Gilson, R; Haddow, LJ; Jit, M; Lacey, C; Meadows, J; Murray, ML; Nathan, M; Nugent, D; Sandmann, F; Soldan, K; Tetlow, M | 1 |
Enomoto, T; Nishijima, K; Sugai, S | 1 |
Harada, K; Irisawa, R; Saito, M; Tsuboi, R | 1 |
Chandran, NS; Heng, LW | 1 |
Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C | 1 |
Ballesteros, J; Calzavara-Pinton, P; Hercogová, J; Lynde, CW; Rotaru, M; Schöfer, H; Skerlev, M; Tatti, S | 1 |
DeAngelis, F; Greenwald, Z; Rampakakis, E; Rodier, C; Steben, M; Stutz, M; Thomas, R | 1 |
Currado, F; Dal Conte, I; DI Benedetto, G; Mistrangelo, M; Morino, M; Testa, V; Volpatto, S | 1 |
Cavezza, S; Liu, X; Mounsey, K; Ni, G; Pan, X; Wang, T; Yuan, J | 1 |
Figueroa, O; Monteagudo, B; Suárez-Amor, O; Varela-Veiga, A | 1 |
Millán-Cayetano, JF; Padilla-España, L; Repiso-Jiménez, JB | 1 |
Clotet, B; García-Cuyás, F; Ornelas, A; Piñol, M; Revollo, B; Sirera, G; Vela, S; Videla, S | 1 |
Fujita, T; Hamano, I; Hashimoto, Y; Hatakeyama, S; Imai, A; Koie, T; Murakami, R; Narumi, S; Ohyama, C; Saitoh, H; Shimada, M; Suzuki, T; Tomita, H; Yamamoto, H; Yoneyama, T | 1 |
Li, M; Lun, W; Song, G; Wu, Y | 1 |
Agim, NG; Chamseddin, BH; Jarin, J; Mir, A; Wilson, EE | 1 |
Nelson, EL; Stockdale, CK | 1 |
Kimura, M; Oshitani, Y; Seishima, M; Tawada, C | 1 |
Lopaschuk, CC | 1 |
Goodpasture, M | 1 |
Scheinfeld, N | 1 |
Cappel, M; Hoesly, F | 1 |
Baker, MG; Morgan, J; Wilson, N | 1 |
Goldstone, SE; Silvera, RJ; Smith, CK; Swedish, KA | 1 |
Hiršl Hećej, V; Ljubojević Hadžavdić, S; Pustišek, N; Sikanić Dugić, N | 1 |
Cao, W; Ge, L; Li, W; Song, H; Xin, H | 1 |
Dar, L; Datt Upadhyay, A; Dwivedi, SN; Gupta, S; Kumar, P; Raj, R; Saldiwal, S; Sharma, VK; Talwar, D; Varma, S; Verma, KK | 1 |
Akhavan, S; Modarres Gillani, M; Mohammadi, SR; Mousavi, AS; Shirazi, M | 1 |
Farah, RS; Vidal, NY; Wanat, KA | 1 |
Bechtel, MA; Trout, W | 1 |
Burillo-Martínez, S; Maroñas-Jiménez, L; Morales-Raya, C; Rodríguez-Peralto, JL; Vanaclocha-Sebastián, F; Velasco-Tamariz, V | 1 |
Dunne, EF; Introcaso, C; Park, IU | 1 |
Ault, K; Nelson, A; Rosen, T | 1 |
Kinoshita, K; Kitamura, T; Matsuda, H; Okai, T; Sekizawa, A; Suzuki, S; Tanaka, M | 1 |
Abadi, R; Abbas, O; Hanna, E | 1 |
de Troya Martín, M; Fernández Morano, MT; García-Montero, P; Repiso Jiménez, JB | 1 |
Long, FQ; Qian, YH; Zhao, LS | 1 |
Blagovidov, DA; Kostinov, MP; Lipatov, IS; Pakhomov, DV; Protasov, AD; Ryzhov, AA; Shmitko, AD; Tezikov, YV; Vekhova, EV; Zhestkov, AV | 1 |
Antoniou, C; Anyfantakis, V; Bethimoutis, G; Eustathios, R; Hadjivassiliou, M; Hagjivassiliou, M; Katsambas, A; Katzouranis, I; Lagogianni, E; Nicolaidou, E; Panagiotopoulos, A; Rallis, E; Stefanaki, C | 1 |
Dunton, C; Mayeaux, EJ | 1 |
Imada, K; Mizuguchi, K; Tsuda, T | 1 |
Ikizoglu, G; Kaya, TI; Tursen, U | 1 |
Brownell, I; Cook, K | 1 |
Alessi, E; Arancio, L; Cusini, M; Gaiani, F; Ramoni, S | 1 |
Arechavala, RS; García-Río, I; González, LC; González-Pérez, R; Michelena, IA; Murua, AA; Santarén, BC; Urra, IT | 1 |
Basar, H; Bozdogan, O; Emeksiz, MC; Erkek, E | 1 |
Takahashi, S; Tsukamoto, T | 1 |
Avola, A; Borzomati, D; Degener, AM; Dianzani, C; Persichetti, P; Pierangeli, A | 1 |
Krishna, S | 1 |
Baguley, S; Delaney, E | 1 |
Antoniou, C; Anyfantakis, V; Bethimoutis, G; Caroni, C; Hadjivassiliou, M; Katsambas, A; Katzouranis, I; Lagogianni, E; Nicolaidou, E; Panagiotopoulos, A; Stefanaki, C | 1 |
Aquilina, C; Bauhofer, A; Bouscarat, F; Dupin, N; Mougin, C; Ortonne, JP; Saiag, P | 1 |
A Gaspari, A; Rosen, T; Tyring, SK | 1 |
Cen, JP; Chen, XZ; Cheng, H; Jin, N; Mao, XH; Ye, J; Zhou, Q; Zhu, KJ | 1 |
Bartlett, BL; Diamantis, ML; Tyring, SK | 1 |
Skinner, RB | 2 |
Burkhart, CN; Culton, DA; Morrell, DS | 1 |
Langley, PC | 1 |
Cohler, M; Schaffer, JV | 1 |
Lee, PK; Wilkins, KB | 1 |
O'Mahony, C; Stanley, M; Yesudian, PD | 1 |
Kemény, L; Nagy, N | 1 |
Taeron, C | 1 |
Chalermchockcharoenkit, A; Neungton, C; Roongpisuthipong, A; Thamkhantho, M; Thanaboonyawat, I | 1 |
Bai, S; Chen, MK; Liao, QM; Ma, CG; Yang, SC | 1 |
Raoulx, M; Skowron, C; Skowron, F | 1 |
Aberer, W; Akkilic-Materna, M; Komericki, P; Strimitzer, T | 1 |
Anadkat, MJ; Bogucki, BA | 1 |
Kim, DH; Kim, JK; Lee, HJ; Yoon, MS | 1 |
Kumar, B; Narang, T | 1 |
Cecchi, S; Ciavattini, A; Di Giuseppe, J; Tranquilli, AL; Tsiroglou, D; Vichi, M | 1 |
Ault, K; Baker, DA; Edwards, L; Ferris, DG; Fife, KH; Levy, S; Liu, T; Martens, MG; Nelson, A; Trofatter, KF; Tyring, SK; Wu, J | 1 |
Barton, DL; Clayton, AC; Gostout, BS; Jefferies, JA; Loprinzi, CL; McGovern, RM; Novotny, PJ; Pachman, DR; Sloan, JA | 1 |
Fuchigami, T; Hashimoto, K; Inadomi, T; Inamo, Y; Masuko, T | 1 |
CostaPinto, L; Grassi, MF; Olavarria, VN; Santiago, MB; Serravalle, K; Travessa, AC | 1 |
Barkas, G; Bethimoutis, G; Katsarou, A; Kontochristopoulos, G; Nicolaidou, E; Papadogeorgaki, H; Stefanaki, C; Valari, M; Verra, P; Vosynioti, V | 1 |
Adams, MP; Barry, GT; Feldman, R; Kulp, J; Levy, S; Wu, J | 1 |
Bakardzhiev, I; Kovachev, E | 1 |
Berman, B; Wolf, J | 1 |
Greensill, A; O'Mahony, C; Yong, M | 1 |
Gormley, RH; Kovarik, CL | 1 |
Black, A; Fleming, N; Leclair, E | 1 |
de Troya-Martín, M; Del Boz, J; Fernández-Morano, T; Frieyro-Elichegui, M; Padilla-España, L; Repiso, JB | 1 |
de Campos Guidi, HG; Rosenblatt, A | 1 |
Brassard, P; Ouhoummane, N; Rodier, C; Steben, M | 1 |
Bourgault-Villada, I; Pavlovic, M; Roudier-Pujol, C; Saiag, P | 1 |
Chan, RK; Chan, YC; Ng, KY | 1 |
Langley, RG; Pearson, GW | 1 |
Birley, H; Clark, F; Sparks, R | 1 |
Rudy, SJ | 1 |
Gruber, PC; Wilkinson, J | 1 |
Dahl, MV | 2 |
Carrasco, D; Tyring, SK; vander Straten, M | 1 |
Beutner, K; Cox, T; Douglas, J; Fife, K; Fukumoto, L; Moscicki, AB; Wiley, DJ | 1 |
Brodersen, JP; Gutzmer, R; Kapp, A; Kaspari, M; Kaspari, T | 1 |
Conant, M; Marini, M; Tyring, S; Van Der Meijden, W; Washenik, K | 1 |
Eul, A; Hagedorn, M; Hopfenmüller, W; Hoyme, UB; Schindler, AE; Schneede, P; Schorn, K | 1 |
Fox, TL; Owens, ML; Sauder, DN; Skinner, RB | 1 |
Badia, X; Vilata, JJ | 1 |
Garland, SM | 1 |
Hamza, S; Skelton, H; Smith, KJ | 1 |
Gunter, J | 1 |
Barton, S; Berman, B; Hengge, U | 1 |
Cusini, M; Hengge, UR | 1 |
Salasche, S; Shumack, S | 1 |
Cox, JT | 1 |
Diakomanolis, E; Elsheikh, A; Haidopoulos, D; Michalas, S; Rodolakis, A; Vlachos, G | 1 |
Dionisi, B; Inghirami, P; Lippa, P; Senatori, R | 1 |
Alessi, E; Carminati, G; Cusini, M; Franchi, C; Locatelli, A; Salmaso, F; Vernaci, C; Zerboni, R | 1 |
Moreno, G; Shumack, S; Tran, H | 1 |
Brady, S; Wilson, JD | 1 |
Berman, B; Cazzaniga, A; Davis, SC; Ricotti, CA | 1 |
Cox, JT; Petry, KU; Roy, M; Rylander, E | 1 |
Frosch, PJ; Herbst, RA; Hölbe, HC; Lange-Ionescu, S | 1 |
Huntley, A; Navi, D | 1 |
Higgins, SP; McQuillan, O | 1 |
Arican, O; Bilgic, K; Guneri, F; Karaoglu, A | 1 |
Usatine, RP | 1 |
Kodner, CM; Nasraty, S | 1 |
Skinner, R | 1 |
Maw, RD | 2 |
Brown, T; Cotsarelis, G; Gelfand, JM; Zirvi, M | 1 |
Costei, A; Einarson, A; Kalra, S; Koren, G; Rouleau, M | 1 |
O'Mahony, C | 2 |
Li, FY; Wang, L; Wang, S; Zhang, M; Zhang, YZ | 1 |
Buck, H | 1 |
Oster-Schmidt, C | 1 |
Aractingi, S; Decuypère, L; Moyse, D; Vexiau, D | 1 |
Altmeyer, P; Brockmeyer, NH; Kreuter, A; Pfister, H; Wafaisade, A; Weissenborn, SJ; Wieland, U | 1 |
Kapembwa, M; Maslen, M; Taylor, CL | 1 |
Cartwright, N; Coyle, A; Fitzgerald, KA; Mitchell, JA; Silverman, N | 1 |
Denham, IM; Garland, SM; McCloskey, JC; Mindel, A; Waddell, R | 1 |
Antoniou, C; Hadjivassiliou, M; Katsambas, A; Nicolaidou, E; Stefanaki, C | 1 |
Liu, YH; Xu, KJ | 1 |
Buck, HW | 2 |
Chen, SL; Wang, HN; Wu, TX; Yan, J | 1 |
Baldauf, JJ; Baulon, E; Nisand, I; Rodriguez, B; Vautravers, A | 1 |
Aoki, T; Beznos, GW; Campaner, AB; Galvão, MA; Santos, RE | 1 |
Al-Dujaili, Z; Hsu, S | 1 |
Brodell, LA; Brodell, RT; Mercurio, MG | 1 |
Correa, LA; Gaviria, A; Herrera, S; Sanclemente, G; Tyring, SK; Wolff, JC | 1 |
Alanbay, I; Baser, I; Dede, M; Guven, S; Kubar, A; Mesten, Z; Yenen, MC | 1 |
Arratia, J; Cortés, JR; Gómez, L; Martínez, R | 1 |
Correa, LA; He, Q; Herrera, S; Rady, PL; Sanclemente, G; Tyring, SK; Wolff, JC; Zuleta, JJ | 1 |
Perry, CM; Wagstaff, AJ | 1 |
Audisio, T; Piatti, C; Roca, FC | 1 |
Schöfer, H | 1 |
Ball, C; Cullins, V; Fine, P; McIntyre, C; Momtaz, M; Morfesis, J; Pelta, M; Rash, RM | 1 |
Dommergues, C; Quinet, B | 1 |
Gotovtseva, EP; Kapadia, AS; Lairson, DR; Smolensky, MH | 1 |
Beutner, KR; Ferenczy, A | 1 |
Baker, D; Edwards, L; Eron, L; Ferenczy, A; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA | 1 |
Beutner, KR; Douglas, JM; Fox, TL; Hougham, AJ; Owens, ML; Spruance, SL | 1 |
Beutner, KR; Douglas, JM; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA; Spruance, S; Trofatter, KF; Tyring, SK | 1 |
Fife, KH | 1 |
Gross, G | 2 |
Arany, I; McDermott, DJ; Miller, RL; Slade, HB; Smith, MH; Stanley, MA; Tomai, MA; Tyring, SK | 2 |
Ahmad, SA; Ahmad, SH; Ahmadpour, OA; Syed, TA | 1 |
Tyring, S | 2 |
Edwards, L | 2 |
Langley, PC; Smith, MH; Tyring, SK | 1 |
Lamb, HM; Perry, CM | 1 |
Conant, MA; Friedman-Kien, AE; Gilson, RJ; Nayagam, AT; Owens, ML; Pietig, DC; Shupack, JL; Smith, MH; Swann, RV; Weber, JN | 1 |
Petersen, CS; Veien, NK | 1 |
Arndt, KA; Dover, JS; Lipper, GM | 1 |
Eggleton, S; Tang, A | 1 |
Maitland, JE; Maw, R | 1 |
Arany, I; Brysk, MM; McDermott, DJ; Miller, RL; Slade, HB; Smith, MH; Stanley, MA; Tomai, MA; Tyring, SK | 1 |
Conant, MA | 1 |
Barrasso, R; Gross, G; Lacey, CJ; Schneider, A; von Krogh, G | 1 |
Davis, G; Richard, J; Wentworth, J | 1 |
Ali, SM; Hadi, SM; Kwah, MS; Qureshi, ZA; Syed, TA | 1 |
Berman, B | 1 |
Fagnani, F | 1 |
Beutner, KR | 1 |
Arrese, J; Claessens, N; Paquet, P; Piérard, G; Piérard-Franchimont, C | 1 |
Barasso, R; Carey-Yard, M; Eul, A; Gollnick, H; Jappe, U; Milde, K; Ward, K | 1 |
Steinhorst, M | 1 |
Brown, DR; Douglas, JM; Ferenczy, A; Fife, KH; Owens, ML; Smith, M | 1 |
Smart, T | 1 |
Edwards, JE; Hicks, D; Hopwood, J; Moore, RA | 1 |
Gall, SA | 1 |
Aractingi, S; Aranda, C; Garland, SM; Maw, RD; Petersen, CS; Sellors, JW; Wikstrom, A | 1 |
Davies, JE | 1 |
Ferenczy, A; Fife, KH; Trofatter, KF | 1 |
Murray, C | 1 |
Bowman, CA; Goh, BT; Kinghorn, GR; Maw, RD; Nathan, M; Nayagam, AT | 1 |
Gayed, SL | 1 |
French, L; Nashelsky, J | 1 |
Buck, HW; Fortier, M; Knudsen, J; Paavonen, J | 1 |
Marini, M | 1 |
Miller, R | 1 |
Eedy, DJ | 1 |
Brodersen, JP; Gutzmer, R; Kapp, A; Kaspari, M; Kiehl, P; Vogelbruch, M; Werfel, T | 1 |
72 review(s) available for imiquimod and Genital Warts
Article | Year |
---|---|
Asian guidelines for condyloma acuminatum.
Topics: Adult; Antiviral Agents; Child; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines | 2022 |
Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis.
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Network Meta-Analysis; Treatment Outcome; Warts | 2020 |
Effectiveness of topical and ablative therapies in treatment of anogenital warts: a systematic review and network meta-analysis.
Topics: Administration, Topical; Antineoplastic Agents; Anus Diseases; Catechin; Caustics; Condylomata Acuminata; Cryosurgery; Electrosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Laser Therapy; Male; Network Meta-Analysis; Papillomaviridae; Podophyllotoxin; Treatment Outcome; Trichloroacetic Acid | 2019 |
A systematic review evaluating the efficacy and safety of a combination of ablative treatment and self administered treatment versus ablative treatment alone for external anogenital warts.
Topics: Aminoquinolines; China; Condylomata Acuminata; Humans; Imiquimod; Treatment Outcome; Warts | 2020 |
Management of Condyloma Acuminata in Pregnancy: A Review.
Topics: Condylomata Acuminata; Female; Humans; Imiquimod; Papillomaviridae; Photochemotherapy; Pregnancy; Recurrence | 2021 |
Sinecatechins and imiquimod as proactive sequential therapy of external genital and perianal warts in adults.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Catechin; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Papillomavirus Infections; Plant Extracts; Tea; Treatment Outcome | 2017 |
Current treatments for anal condylomata acuminata.
Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Condylomata Acuminata; Cryotherapy; Cytotoxins; Electrosurgery; Female; Humans; Imiquimod; Immunologic Factors; Interferons; Laser Therapy; Male; Papillomaviridae; Papillomavirus Infections; Photochemotherapy; Podophyllotoxin | 2018 |
Genital warts treatment: Beyond imiquimod.
Topics: Administration, Topical; Anus Diseases; Catechin; Condylomata Acuminata; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interleukin-10; Papillomaviridae; Recurrence; Treatment Outcome | 2018 |
New approach to managing genital warts.
Topics: Aminoquinolines; Clinical Protocols; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Uterine Cervical Neoplasms | 2013 |
Update on the treatment of genital warts.
Topics: Abnormalities, Drug-Induced; Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Animals; Carcinogenicity Tests; Catechin; Clinical Trials as Topic; Condylomata Acuminata; Dermatologic Agents; Electrocoagulation; Female; Genital Diseases, Female; Genital Diseases, Male; Glycyrrhizic Acid; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hyperthermia, Induced; Imiquimod; Immunotherapy; Incidence; Male; Mice; Mice, Transgenic; Papillomavirus Vaccines; Photochemotherapy; Phytotherapy; Prevalence; Secondary Prevention; United States | 2013 |
Flat-topped and condylomatous papules in a lung transplant patient.
Topics: Aminoquinolines; Biopsy, Needle; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Diagnosis, Differential; Epidermodysplasia Verruciformis; Female; Follow-Up Studies; Humans; Imiquimod; Immunocompromised Host; Immunohistochemistry; Lung Transplantation; Middle Aged; Risk Assessment; Thigh; Transplantation Immunology; Treatment Outcome | 2014 |
Sexually transmitted diseases.
Topics: Acyclovir; Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Chancre; Condylomata Acuminata; Female; Herpes Genitalis; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Penicillins; Podophyllotoxin; Sexually Transmitted Diseases; Syphilis, Cutaneous; Uterine Cervical Neoplasms; Valacyclovir; Valine | 2015 |
Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Topics: Adolescent; Aminoquinolines; Antiviral Agents; Anus Neoplasms; Centers for Disease Control and Prevention, U.S.; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomavirus Infections; Papillomavirus Vaccines; Practice Guidelines as Topic; Prevalence; United States; Young Adult | 2015 |
Imiquimod in dermatology: an overview.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Prognosis; Skin Diseases; Skin Neoplasms; Treatment Outcome | 2016 |
Modern management of external genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Camellia sinensis; Catechin; Condylomata Acuminata; Female; Humans; Imiquimod; Keratolytic Agents; Phytotherapy; Podophyllotoxin | 2008 |
[Pharmacological and clinical profile of imiquimod (BESELNA CREAM 5%)].
Topics: Aminoquinolines; Animals; Condylomata Acuminata; Guinea Pigs; Humans; Imiquimod; Interferon Inducers; Ointment Bases | 2008 |
Treatments for genital warts.
Topics: Adolescent; Adult; Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Cryotherapy; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Neurosurgical Procedures; Papillomavirus Vaccines; Podophyllotoxin | 2008 |
[Condyloma acuminatum].
Topics: Age Factors; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Male; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Secondary Prevention; Sex Factors; Sexually Transmitted Diseases, Viral; Urogenital Surgical Procedures | 2009 |
[Genital warts].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Keratolytic Agents; Male; Medical History Taking; Ointments; Podophyllotoxin; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2009 |
Beyond a decade of 5% imiquimod topical therapy.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Keratosis, Actinic; Papillomavirus Infections; Skin Diseases; Skin Neoplasms; Toll-Like Receptor 7 | 2009 |
Imiquimod as an immune response modulator in infectious conditions.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Child; Condylomata Acuminata; Humans; Imiquimod; Leishmaniasis, Cutaneous; Molluscum Contagiosum | 2002 |
The management of condyloma acuminata in the pediatric population.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cimetidine; Condylomata Acuminata; Cryotherapy; Cytosine; Dermatologic Surgical Procedures; Female; Histamine H2 Antagonists; Humans; Imiquimod; Keratolytic Agents; Laser Therapy; Lasers, Dye; Lasers, Gas; Male; Organophosphonates; Papillomavirus Infections; Podophyllotoxin; Skin; Treatment Outcome | 2009 |
Condyloma and other infections including human immunodeficiency virus.
Topics: Aminoquinolines; Anti-Bacterial Agents; Antineoplastic Agents; Anus Neoplasms; Chancroid; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Imiquimod; Male; Penicillin G; Proctitis; Rectal Diseases; Sexually Transmitted Diseases; Syphilis; Ulcer | 2010 |
[New perspective in immunotherapy: local imiquimod treatment].
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antiviral Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Humans; Imiquimod; Immunity, Innate; Keratosis, Actinic; Langerhans Cells; Off-Label Use; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors | 2010 |
Topical Imiquimod 5% cream therapy for external anogenital warts in pregnant women: report of four cases and review of the literature.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Pregnancy; Pregnancy Complications; Young Adult | 2012 |
[Comparative assessment of the methods of treatment of Condylomata acuminata].
Topics: Alphapapillomavirus; Aminoquinolines; Antimetabolites; Caustics; Condylomata Acuminata; Cryotherapy; Electrosurgery; Female; Fluorouracil; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Podophyllin; Trichloroacetic Acid | 2011 |
Human papillomavirus-related genital disease in the immunocompromised host: Part II.
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Anus Neoplasms; Buschke-Lowenstein Tumor; Catechin; Caustics; Cidofovir; Condylomata Acuminata; Counseling; Cryotherapy; Cytosine; Female; Humans; Imiquimod; Immunocompromised Host; Male; Ointments; Organophosphonates; Papillomavirus Infections; Penile Neoplasms; Podophyllotoxin; Precancerous Conditions; Treatment Outcome; Trichloroacetic Acid; Vaginal Neoplasms; Vulvar Neoplasms; Warts | 2012 |
[Treatment of anogenital warts with topical cidofovir].
Topics: Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Anus Diseases; Child; Cidofovir; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Cytosine; Disease Susceptibility; Drug Evaluation; Drug Resistance, Viral; Electrocoagulation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunocompetence; Male; Organophosphonates; Podophyllotoxin; Remission Induction; Retrospective Studies; Young Adult | 2013 |
Topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Ointments | 2001 |
Imiquimod (Aldara): modifying the immune response.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Herpes Simplex; Humans; Imiquimod; Molluscum Contagiosum; Skin Neoplasms; Warts | 2002 |
Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Recurrence; Retrospective Studies; Time Factors | 2002 |
Imiquimod; an international update on therapeutic uses in dermatology.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma; Condylomata Acuminata; Dermatologic Agents; DNA Virus Infections; Humans; Imiquimod; Immunocompromised Host; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2002 |
Imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Skin Neoplasms | 2003 |
Imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Humans; Imiquimod; Papillomavirus Infections; Randomized Controlled Trials as Topic; Skin Diseases, Infectious | 2003 |
The imidazoquinolines and their place in the therapy of cutaneous disease.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Skin Neoplasms | 2003 |
Genital and perianal warts: new treatment opportunities for human papillomavirus infection.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Age Distribution; Aminoquinolines; Antiviral Agents; Combined Modality Therapy; Condylomata Acuminata; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Incidence; Middle Aged; Papillomaviridae; Perineum; Prognosis; Risk Assessment; Severity of Illness Index; Sexually Transmitted Diseases; Tumor Virus Infections | 2003 |
Successful management of viral infections and other dermatoses with imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma in Situ; Child; Condylomata Acuminata; Female; Humans; Imiquimod; Keloid; Male; Middle Aged; Molluscum Contagiosum; Skin Diseases; Virus Diseases; Vulvar Neoplasms | 2003 |
Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Immunocompromised Host; Male; Molluscum Contagiosum; Papillomaviridae; Randomized Controlled Trials as Topic; Skin Diseases, Viral; Tumor Virus Infections | 2003 |
A review of imiquimod 5% cream for the treatment of various dermatological conditions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Emollients; Female; Humans; Imiquimod; Male; Membrane Glycoproteins; Ointments; Receptors, Cell Surface; Skin Diseases; Toll-Like Receptors | 2003 |
Imiquimod as a dermatological therapy.
Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic | 2004 |
Using imiquimod for genital warts in female patients.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Quality of Life; Recurrence; Risk Factors; Viral Load; Vulvar Neoplasms; Women's Health | 2004 |
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2004 |
Pearly penile lesions.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Cryosurgery; Diagnosis, Differential; Drug Administration Schedule; Humans; Imiquimod; Keratolytic Agents; Male; Penile Diseases; Penis; Podophyllin; Podophyllotoxin; Self Administration; Skin Diseases, Papulosquamous; Treatment Outcome; Trichloroacetic Acid | 2004 |
Management of genital warts.
Topics: Algorithms; Aminoquinolines; Condylomata Acuminata; Cryotherapy; Decision Trees; Diagnosis, Differential; Electrosurgery; Evidence-Based Medicine; Family Practice; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Keratolytic Agents; Laser Therapy; Male; Patient Selection; Podophyllotoxin; Practice Guidelines as Topic; Primary Health Care; Treatment Outcome | 2004 |
Role of topical therapies in the management of cutaneous disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Dermatitis, Atopic; Dermatitis, Seborrheic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Toll-Like Receptors | 2004 |
Genital warts: current and future management options.
Topics: Adjuvants, Immunologic; Algorithms; Aminoquinolines; Caustics; Condylomata Acuminata; Cryotherapy; Humans; Imiquimod; Keratolytic Agents; Podophyllotoxin; Risk Factors; Trichloroacetic Acid | 2005 |
Genital warts.
Topics: Aminoquinolines; Condoms; Condylomata Acuminata; Cryotherapy; Electrosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferons; Male; Podophyllin; Podophyllotoxin | 2005 |
Genital warts.
Topics: Aminoquinolines; Condoms; Condylomata Acuminata; Cryotherapy; Electrosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Interferons; Laser Therapy; Male; Podophyllin; Podophyllotoxin; Trichloroacetic Acid | 2006 |
Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
Topics: Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Databases, Factual; Humans; Imiquimod; Keratolytic Agents; Podophyllotoxin; Randomized Controlled Trials as Topic | 2006 |
[Imiquimod and immune response modifiers in gynaecology].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Papillomavirus Infections; Treatment Outcome; Uterine Cervical Dysplasia | 2007 |
The diagnosis and treatment of human papillomavirus-mediated genital lesions.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Humans; Imiquimod; Keratolytic Agents; Podophyllotoxin; Self Administration | 2007 |
Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Photosensitivity Disorders; Skin Diseases; Skin Neoplasms | 2007 |
Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Topics: Aminoquinolines; Anus Diseases; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Male; Treatment Outcome | 2007 |
Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis.
Topics: Adult; Aminoquinolines; Circumcision, Male; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Immunocompetence; Interferon Inducers; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Therapeutic approaches to genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Antiviral Agents; Condylomata Acuminata; Cryotherapy; Drug Therapy, Combination; Electrosurgery; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferons; Keratolytic Agents; Laser Therapy; Papillomaviridae; Papillomavirus Infections; Podophyllin; Podophyllotoxin; Tumor Virus Infections | 1997 |
Therapy of human papillomavirus infection and associated epithelial tumors.
Topics: Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Interferons; Laser Therapy; Neoplasms, Glandular and Epithelial; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaccines, Synthetic | 1997 |
Imiquimod (Aldara cream).
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Drug Interactions; Female; Humans; Imiquimod; Male | 1998 |
Treatment of anogenital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Caustics; Condylomata Acuminata; Cryosurgery; Electrosurgery; Humans; Imiquimod; Immunity, Cellular; Immunologic Factors; Immunotherapy; Interferon Inducers; Keratolytic Agents; Laser Therapy; Recurrence; Treatment Failure; Treatment Outcome | 1998 |
Topical imiquimod: a review of its use in genital warts.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Clinical Trials as Topic; Condylomata Acuminata; Female; Humans; Imiquimod; In Vitro Techniques | 1999 |
[Imiquimod creme 5 per cent--a new agent for topical treatment of external condylomata].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers | 1999 |
Imiquimod in clinical practice.
Topics: Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Papillomaviridae; Tumor Virus Infections | 2000 |
[Imiquimod: immunologic-response modifier].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Interferon Inducers; Interferons; Langerhans Cells; Papillomaviridae; RNA, Messenger | 2000 |
[Medico-economic analysis of therapy of external condylomata acuminata].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Drug Evaluation; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Laser Therapy; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence | 2000 |
[Imiquimod--clinical efficacy].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Penile Diseases; Randomized Controlled Trials as Topic | 2000 |
[Clinical aspects and therapy of anogenital warts and papillomavirus-associated lesions].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Caustics; Child; Child, Preschool; Condylomata Acuminata; Controlled Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Electrosurgery; Female; Humans; Imiquimod; Injections, Intralesional; Interferon Inducers; Interferons; Keratolytic Agents; Male; Ointments; Papillomaviridae; Papillomavirus Infections; Podophyllotoxin; Time Factors; Trichloroacetic Acid; Tumor Virus Infections | 2001 |
Imiquimod applied topically: A novel immune response modifier.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Issues and practicalities of treating genital warts in the community. Proceedings of a round table meeting facilitated by Succinct Communications Limited.
Topics: Aminoquinolines; Antineoplastic Agents; Community Health Services; Condylomata Acuminata; Humans; Imiquimod; Podophyllotoxin; United Kingdom | 2001 |
Imiquimod for the treatment of genital warts: a quantitative systematic review.
Topics: AIDS-Related Opportunistic Infections; Aminoquinolines; Clinical Trials as Topic; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Retrospective Studies; Treatment Outcome | 2001 |
Female genital warts: global trends and treatments.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Global Health; Health Knowledge, Attitudes, Practice; Humans; Imiquimod; Incidence; Papillomavirus Infections; Prevalence; Risk Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
Hide and seek. Make sure HPV infection doesn't escape diagnosis.
Topics: Adjuvants, Immunologic; Aminoquinolines; Biopsy; Condylomata Acuminata; Contraindications; Cryotherapy; Diagnosis, Differential; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Keratolytic Agents; Male; Podophyllin; Pregnancy | 2000 |
Clinical inquiries. What is the most effective treatment for external genital warts?
Topics: Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Cryosurgery; Electrosurgery; Evidence-Based Medicine; Humans; Imiquimod; Interferons; Keratolytic Agents; Laser Therapy; Podophyllin; Podophyllotoxin; Trichloroacetic Acid | 2002 |
Imiquimod: a potential role in dermatology?
Topics: Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Humans; Imiquimod; Interferon Inducers; Keratosis; Skin Diseases; Skin Neoplasms | 2002 |
36 trial(s) available for imiquimod and Genital Warts
Article | Year |
---|---|
Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers.
Topics: Administration, Cutaneous; Adolescent; Adult; Alphapapillomavirus; Antimicrobial Cationic Peptides; Carcinoma in Situ; Condylomata Acuminata; Drug Synergism; Drug Therapy, Combination; Female; Healthy Volunteers; Humans; Imiquimod; Male; Middle Aged; Proof of Concept Study; Skin; Vulvar Neoplasms; Young Adult | 2020 |
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
Topics: Adjuvants, Immunologic; Adult; Condylomata Acuminata; Drug Therapy, Combination; England; Female; Homosexuality, Male; Humans; Imiquimod; Keratolytic Agents; Male; Papillomavirus Vaccines; Podophyllotoxin; Secondary Prevention; Treatment Outcome; Wales; Young Adult | 2020 |
Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Bacterial Vaccines; Condylomata Acuminata; DNA, Viral; Female; Human papillomavirus 11; Humans; Imiquimod; Injections, Intralesional; Male; Skin Cream; Viral Load; Young Adult | 2014 |
Efficacy of combination therapy of oral zinc sulfate with imiquimod, podophyllin or cryotherapy in the treatment of vulvar warts.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aminoquinolines; Astringents; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Female; Humans; Imiquimod; Interferon Inducers; Iran; Keratolytic Agents; Middle Aged; Patient Dropouts; Podophyllin; Secondary Prevention; Skin Cream; Vulvar Diseases; Young Adult; Zinc Sulfate | 2014 |
Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Imiquimod; Male; Treatment Outcome | 2015 |
Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Cryotherapy; Drug Administration Schedule; Genital Diseases, Male; Humans; Imiquimod; Male; Secondary Prevention; Treatment Outcome | 2008 |
Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Male; Middle Aged; Papillomavirus Infections; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Intention to Treat Analysis; Keratolytic Agents; Male; Middle Aged; Podophyllotoxin; Treatment Outcome; Young Adult | 2011 |
Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Data Interpretation, Statistical; Female; Genital Diseases, Female; Humans; Imiquimod; Middle Aged; Placebos; Treatment Outcome | 2011 |
Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Condylomata Acuminata; Drug Administration Routes; Female; Humans; Imiquimod; Papillomavirus Infections; Severity of Illness Index; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2012 |
Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts.
Topics: Adult; Aminoquinolines; Anus Diseases; Biotransformation; Condylomata Acuminata; Drug Eruptions; Female; Groin; Half-Life; Humans; Imiquimod; Immunologic Factors; Incidence; Male; Ointments; Perineum; Self Administration; Severity of Illness Index; Toll-Like Receptor 7; Warts; Young Adult | 2012 |
Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma.
Topics: Adult; Aminoquinolines; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Secondary Prevention; Suppositories | 2002 |
Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Female; Humans; Imiquimod; Laser Therapy; Male; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Recurrence; Treatment Outcome | 2002 |
Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Male; Treatment Outcome | 2003 |
Safety and efficacy of locally applied imiquimod cream 5% for the treatment of condylomata acuminata of the vulva.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Ointments; Treatment Outcome; Vulvar Diseases | 2004 |
Imiquimod as a dermatological therapy.
Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic | 2004 |
Topical imiquimod 5% cream in external anogenital warts: a randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Treatment Outcome | 2004 |
[Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome | 2005 |
An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Middle Aged; Time Factors; Treatment Outcome | 2006 |
Effect of imiquimod in anogenital warts from HIV-positive men.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; Genital Diseases, Male; HIV Infections; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Secondary Prevention; Treatment Outcome | 2007 |
Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; DNA, Viral; Female; Humans; Imiquimod; Papillomaviridae; Polymerase Chain Reaction; Prospective Studies; Treatment Outcome; Vulvar Diseases | 2007 |
Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anus Diseases; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; Genital Diseases, Male; Humans; Imiquimod; Male; Middle Aged; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Treatment Outcome; Viral Load | 2007 |
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Dermatitis; Double-Blind Method; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Incidence; Interferon Inducers; Male; Ointments; Pharmaceutical Vehicles; Placebos; Recurrence; Remission Induction; Safety; Self Administration; Treatment Outcome | 1998 |
Treatment of genital warts with an immune-response modifier (imiquimod).
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Prospective Studies | 1998 |
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Papillomaviridae; Recurrence | 1998 |
A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Cytokines; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Male; RNA, Messenger; Treatment Outcome | 1998 |
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Ointments; Papillomaviridae; Papillomavirus Infections; Placebos; Recurrence; Remission Induction; Tumor Virus Infections; Vulvar Diseases | 1998 |
Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
Topics: Adolescent; Adult; Aminoquinolines; Antigens, CD; Cell Differentiation; Cell Division; Condylomata Acuminata; Cytokines; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Keratinocytes; Male; Middle Aged; Papillomaviridae; Polymerase Chain Reaction; RNA, Messenger; Viral Load | 1999 |
A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Double-Blind Method; Drug Eruptions; Female; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Safety | 1999 |
Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts.
Topics: Aminoquinolines; Biopsy; Cell Differentiation; Condylomata Acuminata; DNA-Binding Proteins; Double-Blind Method; Gene Expression Regulation; Humans; Imiquimod; Interferon Inducers; Interferons; Keratinocytes; Protein Inhibitors of Activated STAT; Proteins; RNA, Messenger; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators | 2000 |
Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Cytokines; Double-Blind Method; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Polymerase Chain Reaction | 2000 |
Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Erythema; France; Germany; Humans; Imiquimod; Interferon Inducers; Male; Pain; Penile Diseases; Pruritus | 2001 |
Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day.
Topics: Adult; Aged; Aminoquinolines; Antibodies, Viral; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Neopterin; Papillomaviridae; Ulcer | 2001 |
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Anti-Infective Agents; Condylomata Acuminata; Consumer Product Safety; Demography; Female; Follow-Up Studies; Health Personnel; Humans; Imiquimod; Male; Middle Aged; Recurrence; Self Administration; Surveys and Questionnaires; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2001 |
Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Drug Administration Schedule; Female; Genital Diseases, Female; Humans; Imiquimod | 2002 |
Imiquimod 5% cream is an acceptable treatment option for external anogenital warts in uncircumcised males.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Penile Diseases; Treatment Outcome | 2002 |
118 other study(ies) available for imiquimod and Genital Warts
Article | Year |
---|---|
Florid anogenital warts in a 7-month-old boy with rapid response to imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Infant; Male; Treatment Outcome; Warts | 2022 |
5-Fluorouracil 0.5%/salicylic acid 10% solution in the treatment of ano-genital warts.
Topics: Adult; Condylomata Acuminata; Female; Fluorouracil; Humans; Imiquimod; Male; Pain; Salicylic Acid; Treatment Outcome; Warts | 2022 |
Extensive condyloma acuminata: Complete remission after oral isotretinoin and topical imiquimod. A successful combination?
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Isotretinoin; Remission Induction | 2022 |
Imiquimod-Associated Localized Skin Ulceration in a Patient With Uncontrolled Diabetes.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Diabetes Mellitus, Type 2; Humans; Imiquimod | 2022 |
Meatal Intraurethral Warts Successfully Treated with 5-fluorouracil Cream.
Topics: Adult; Condylomata Acuminata; Fluorouracil; Humans; Imiquimod; Male; Papillomaviridae; Trichloroacetic Acid; Warts | 2022 |
The effectiveness and tolerability of imiquimod suppositories to treat extensive intra-anal high-grade squamous intraepithelial lesions/warts in HIV-infected individuals.
Topics: Adjuvants, Immunologic; Administration, Rectal; Anal Canal; Anus Neoplasms; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Squamous Intraepithelial Lesions; Suppositories; Treatment Outcome; Warts | 2019 |
Spontaneous regression of genital warts at untreated sites following electrocoagulation treatment for lesions at the other sites.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Electrocoagulation; Human papillomavirus 6; Humans; Imiquimod; Male; Perineum; Remission, Spontaneous; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome | 2020 |
[Prevalence and management of condylomas in consulting population in Chile: "DIACON study"].
Topics: Adolescent; Adult; Antineoplastic Agents; Chile; Condylomata Acuminata; Demography; Dermatologists; Female; Gynecology; Health Facilities, Proprietary; Health Surveys; Humans; Imiquimod; Incidence; Male; Middle Aged; Outpatients; Prevalence; Primary Health Care; Professional Practice; Urologists; Young Adult | 2019 |
An Alternative Treatment for Vaginal Cuff Wart: a Case Report.
Topics: Adjuvants, Immunologic; Antineoplastic Agents; beta-Glucans; Colposcopy; Condylomata Acuminata; Curcumin; Drug Combinations; Fatty Alcohols; Female; Humans; Imiquimod; Lactic Acid; Middle Aged; Papanicolaou Test; Papillomavirus Infections; Phyllanthus emblica; Phytotherapy; Plant Preparations; Squamous Intraepithelial Lesions of the Cervix; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2020 |
Successful topical treatment of anal giant condylomata acuminata in an infant.
Topics: Administration, Topical; Aminoquinolines; Child; Condylomata Acuminata; Humans; Imiquimod; Infant; Neoplasm Recurrence, Local | 2020 |
Complete healing of perianal giant condyloma (buschke-löwenstein tumor) with imiquimod 5% cream alone.
Topics: Anus Neoplasms; Buschke-Lowenstein Tumor; Condylomata Acuminata; Humans; Imiquimod; Perineum | 2020 |
Treatment of intra-anal warts with imiquimod 5% cream: A single-center prospective open study.
Topics: Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Prospective Studies; Treatment Outcome; Warts | 2021 |
Impetigo as an adverse effect of topical 5% imiquimod treatment for viral warts.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Impetigo; Treatment Outcome; Warts | 2021 |
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.
Topics: Administration, Topical; Adult; Aminoquinolines; Canada; Condylomata Acuminata; Cryotherapy; Female; Health Knowledge, Attitudes, Practice; Human papillomavirus 6; Humans; Imiquimod; Male; Papillomavirus Infections; Prevalence; Recurrence; Retrospective Studies; Unsafe Sex; Young Adult | 2017 |
Genital Warts, Lymphangioma, and Treatment with Imiquimod.
Topics: Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Lymphangioma; Vulva | 2018 |
Genital Warts, Lymphangioma, and Treatment with Imiquimod.
Topics: Adult; Antineoplastic Agents; Condylomata Acuminata; Diagnosis, Differential; Female; Humans; Imiquimod; Lymphangioma; Vulvar Neoplasms | 2018 |
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Retroviral Agents; Anus Diseases; Condylomata Acuminata; Electrosurgery; Genotype; HIV Infections; Homosexuality, Male; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Infrared Rays; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Condyloma Acuminata of the Urethra in a Male Renal Transplant Recipient: A Case Report.
Topics: Adult; Condylomata Acuminata; Everolimus; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Tacrolimus; Transplant Recipients; Urethral Diseases | 2018 |
Condyloma acuminata on the nipple and coronary sulcus of the penis: A case report.
Topics: Adult; Condylomata Acuminata; Diagnosis, Differential; Human papillomavirus 6; Humans; Imiquimod; Male; Nipples; Penis | 2019 |
Therapy for anogenital verrucae in preadolescent children with topical and systemic treatment.
Topics: Administration, Topical; Antineoplastic Agents; Antioxidants; Catechin; Child; Child, Preschool; Combined Modality Therapy; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Infant; Male; Retrospective Studies; Treatment Outcome | 2019 |
Vulvar and vaginal HPV disease.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult | 2013 |
Successful treatment of anal and perianal condyloma acuminata with imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Young Adult | 2014 |
A 4-year-old girl who presents with repeated episodes of vaginal bleeding found to have anogenital warts.
Topics: Aminoquinolines; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Diagnosis, Differential; Female; Hemorrhage; Humans; Imiquimod; Recurrence; Vaginal Diseases | 2013 |
Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child; Condylomata Acuminata; Drug Prescriptions; Female; Humans; Imiquimod; New Zealand; Papillomavirus Infections; Papillomavirus Vaccines; Pharmacies; Podophyllotoxin; Program Evaluation; Treatment Outcome; Vaccination | 2014 |
Anal condyloma treatment and recurrence in HIV-negative men who have sex with men.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Anus Diseases; Chemotherapy, Adjuvant; Condylomata Acuminata; Disease-Free Survival; Electrocoagulation; HIV Seronegativity; Homosexuality, Male; Humans; Imiquimod; Lasers, Gas; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Young Adult | 2014 |
Treatment of anogenital warts in an 18-month-old girl with 5% imiquimod cream.
Topics: Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Infant; Interferon Inducers; Skin Cream; Vulvar Diseases | 2014 |
Induction of vitiligo after imiquimod treatment of condylomata acuminata.
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Vitiligo | 2014 |
Dramatic saxophone penis as a result of topical imiquimod use.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Edema; Humans; Imiquimod; Male; Middle Aged; Penile Diseases; Penis | 2014 |
Aphthous vulvar ulcers: a paradoxal adverse effect at distance of topical imiquimod?
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Ulcer; Vulvar Diseases | 2016 |
Current Status of Condylomata Acuminata in Pregnant Japanese Women.
Topics: Adolescent; Adult; Age Factors; Aminoquinolines; Cesarean Section; Condylomata Acuminata; Disease Management; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Japan; Papillomavirus Infections; Practice Guidelines as Topic; Pregnancy; Prevalence; Respiratory Tract Infections | 2016 |
Genital Vitiligo-like Hypopigmentation After Treatment With 5% Imiquimod.
Topics: Adult; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Female; Genital Diseases, Male; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Vitiligo; Vulvar Diseases | 2017 |
Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Vitiligo | 2017 |
[Anogenital warts: a new way of solving the common problem of urology (results of long-term follow-up)].
Topics: Acetic Acid; Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Copper; Dermatologic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Lactates; Male; Nitrates; Ointments; Papillomavirus Infections; Papillomavirus Vaccines; Vaccines, Synthetic; Young Adult | 2016 |
Large genital ulcers in a patient with Behçet's disease associated with imiquimod cream treatment for external genital warts.
Topics: Adult; Aminoquinolines; Behcet Syndrome; Condylomata Acuminata; Drug Eruptions; Female; Humans; Imiquimod; Interferon Inducers; Skin Ulcer; Vulvar Diseases | 2008 |
Penile intraepithelial carcinoma treated with imiquimod 1% in an HIV-positive patient.
Topics: Administration, Topical; Aminoquinolines; Anti-HIV Agents; Carcinoma in Situ; Cell Transformation, Neoplastic; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; HIV Infections; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Staging; Penile Diseases; Penile Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2009 |
Coexisting perianal squamous cell carcinoma, Bowen's disease, and condylomata acuminata treated with topical imiquimod 5%.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Anus Neoplasms; Bowen's Disease; Carcinoma, Squamous Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms | 2008 |
Giant condyloma acuminata of Buschke-Löwenstein: successful treatment with a combination of surgical excision, oral acitretin and topical imiquimod.
Topics: Acitretin; Administration, Oral; Administration, Topical; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Drug Therapy, Combination; Humans; Imiquimod; Keratolytic Agents; Male; Middle Aged; Penile Diseases | 2009 |
Intra-anal condyloma: surgical or topical treatment?
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Laser Therapy; Male; Ointments; Retreatment; Skin Diseases; Treatment Outcome | 2008 |
Comparison of podophyllotoxin and imiquimod as anal condyloma acuminata therapy.
Topics: Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Podophyllotoxin | 2009 |
Prognostic factors for the response to treatment in males with genital warts.
Topics: Adolescent; Adult; Aminoquinolines; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Genital Diseases, Male; Humans; Imiquimod; Male; Middle Aged; Podophyllotoxin; Prognosis | 2009 |
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells.
Topics: Aminoquinolines; Antigen Presentation; Cell Differentiation; Cells, Cultured; Colonic Neoplasms; Condylomata Acuminata; Cytotoxicity, Immunologic; Dendritic Cells; Epitopes, T-Lymphocyte; Female; HLA-A Antigens; HLA-A2 Antigen; Human papillomavirus 11; Humans; Imiquimod; Interferon-gamma; Lipopolysaccharides; Lymphocyte Activation; Monocytes; Oligonucleotides; Oncogene Proteins, Viral; Poly I-C; Th1 Cells; Toll-Like Receptors; Tumor Virus Infections; Uterine Cervical Neoplasms; Viral Vaccines | 2010 |
Safety, efficacy & recurrence rates of imiquimod cream 5% for treatment of anogenital warts.
Topics: Administration, Cutaneous; Aminoquinolines; Anus Diseases; Combined Modality Therapy; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Male; Secondary Prevention | 2009 |
A cost-effectiveness analysis of sinecatechins in the treatment of external genital warts.
Topics: Aminoquinolines; Antineoplastic Agents; Camellia sinensis; Catechin; Condylomata Acuminata; Confidence Intervals; Cost-Benefit Analysis; Decision Support Techniques; Drug Utilization; Humans; Imiquimod; Models, Economic; Plant Extracts; Treatment Outcome; United States | 2010 |
Successful treatment of massive anogenital warts in a two-year-old boy with imiquimod and cimetidine immunotherapy.
Topics: Aminoquinolines; Cimetidine; Condylomata Acuminata; Humans; Imiquimod; Infant; Male; Treatment Outcome | 2009 |
Imiquimod use in the genital area and development of lichen sclerosus and lichen planus.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Circumcision, Male; Condylomata Acuminata; Humans; Imiquimod; Lichen Planus; Lichen Sclerosus et Atrophicus; Male | 2010 |
[Imiquimod cream. A cream to use with precaution].
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Drug Eruptions; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome | 2010 |
Current therapy for condyloma acuminata of the patients attending female STD Unit, Siriraj Hospital.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Caustics; Cautery; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Ointments; Podophyllin; Retrospective Studies; Treatment Outcome; Trichloroacetic Acid; Young Adult | 2010 |
Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Cervix Uteri; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Recurrence | 2010 |
[Topical imiquimod for the treatment of anogenital warts in an infant].
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Anus Diseases; Condylomata Acuminata; Drug Eruptions; Follow-Up Studies; Genital Diseases, Male; Hospitalization; Humans; Imiquimod; Infant; Inguinal Canal; Male; Skin; Skin Ulcer; Treatment Outcome | 2010 |
Development of adenopathy during the use of topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Burkitt Lymphoma; Comorbidity; Condylomata Acuminata; HIV Seropositivity; Humans; Imiquimod; Lymphatic Diseases; Male; Positron-Emission Tomography | 2011 |
Condyloma accuminatum treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, 18).
Topics: Adjuvants, Immunologic; Alphapapillomavirus; Aminoquinolines; Condylomata Acuminata; Dermis; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Papillomavirus Vaccines; Vaccines, Synthetic | 2011 |
Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Arthralgia; Condylomata Acuminata; Fever; Headache; Humans; Imiquimod; Immunity, Cellular; Immunocompetence; Male; Ointments; Prospective Studies | 2011 |
Effectiveness of imiquimod 5% cream for treatment of perianal warts in a 28-month-old child.
Topics: Adjuvants, Immunologic; Aminoquinolines; Child, Preschool; Condylomata Acuminata; Female; Humans; Imiquimod; Ointments | 2011 |
Giant disseminated condylomatosis in SLE.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Papillomaviridae; Podophyllin; Treatment Outcome; Trichloroacetic Acid | 2012 |
Condylomata acuminata in children.
Topics: Aminoquinolines; Antineoplastic Agents; Child; Child, Preschool; Condylomata Acuminata; Cryotherapy; Female; Humans; Imiquimod; Infant; Male; Perineum; Podophyllotoxin; Treatment Outcome | 2012 |
The role of imiquimod 3.75% cream in the treatment of external genital warts.
Topics: Administration, Topical; Aminoquinolines; Canada; Clinical Trials, Phase III as Topic; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Approval; Humans; Imiquimod; Interferon Inducers; Plant Extracts; Tea; United States; United States Food and Drug Administration | 2012 |
Imiquimod use in adolescents: off-label but effective.
Topics: Adolescent; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Immunologic Factors; Male; Treatment Outcome | 2012 |
Imiquimod 5% cream treatment for rapidly progressive genital condyloma in a 3-year-old girl.
Topics: Aminoquinolines; Child, Preschool; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers | 2012 |
[Item 149--Epithelial and melanotic skin tumors: human papillomavirus (HPV) tumors].
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Child; Combined Modality Therapy; Condylomata Acuminata; Cryosurgery; Cryotherapy; Female; Gammapapillomavirus; Humans; Imiquimod; Immunocompromised Host; Laser Therapy; Lasers, Gas; Male; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Risk; Skin Neoplasms; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaccination; Warts | 2012 |
Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases.
Topics: Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged | 2012 |
Temporal trends in genital warts among individuals covered by the public prescription drug insurance plan in the province of Quebec, Canada, from 1998 to 2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Condylomata Acuminata; Drug Prescriptions; Drug Utilization; Female; Fluorouracil; Humans; Imiquimod; Incidence; Insurance Claim Review; Male; Middle Aged; Podophyllotoxin; Prevalence; Quebec; Young Adult | 2013 |
Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-HIV Agents; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Male; Middle Aged; Penile Diseases; Treatment Outcome | 2002 |
The epidemiology and treatment of anogenital warts in Singapore: a retrospective evaluation.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Cost-Benefit Analysis; Cryosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Keratolytic Agents; Male; Middle Aged; Outcome Assessment, Health Care; Podophyllin; Recurrence; Retrospective Studies; Singapore | 2002 |
Cost-effectiveness of imiquimod for anogenital warts.
Topics: Aminoquinolines; Anti-Infective Agents; Anus Diseases; Condylomata Acuminata; Cost-Benefit Analysis; Female; Humans; Imiquimod; Male; Treatment Outcome | 2002 |
Successful treatment of perianal warts in a child with 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Infant; Male | 2001 |
Imiquimod: a cytokine inducer.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Cytokines; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Diseases, Viral; Tumor Virus Infections; Warts | 2002 |
External genital warts: diagnosis, treatment, and prevention.
Topics: Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Cryotherapy; Education; Electrosurgery; Female; Floxuridine; Humans; Imiquimod; Interferons; Laser Therapy; Male; Papillomaviridae; Papillomavirus Infections; Podophyllin; Podophyllotoxin; Tumor Virus Infections | 2002 |
Effectiveness, satisfaction and compliance with imiquimod in the treatment of external anogenital warts.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Male; Ointments; Patient Compliance; Prospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2003 |
Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Ointments; Treatment Outcome | 2003 |
[Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Condylomata Acuminata; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Middle Aged; Papillomavirus Infections; Vaginal Creams, Foams, and Jellies | 2003 |
5% Imiquimod cream for external anogenital warts in HIV-infected patients under HAART therapy.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Anus Diseases; Case-Control Studies; Condylomata Acuminata; Drug Administration Schedule; Female; HIV Infections; Humans; Imiquimod; Male; Severity of Illness Index; Treatment Outcome | 2004 |
Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
Topics: Aminoquinolines; Biopsy, Needle; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Feedback; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunohistochemistry; Incidence; Interferon Inducers; Male; Medical Audit; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome; United Kingdom | 2004 |
Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Condylomata Acuminata; Female; Humans; Imiquimod; Keratosis; Swine | 2004 |
[Condylomata acuminata gigantea. Surgical and combined immunomodulatory therapy].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Disease-Free Survival; Drug Combinations; Female; Genital Diseases, Female; Humans; Imiquimod; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Treatment Outcome | 2004 |
Acute urinary retention following self treatment of genital warts with imiquimod 5% cream.
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Self Administration; Urinary Retention | 2004 |
Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Humans; Imiquimod; Ointments; Pregnancy; Pregnancy Complications, Infectious; Vulvar Neoplasms | 2004 |
Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Genital Diseases, Male; Humans; Hypopigmentation; Imiquimod; Male | 2005 |
The use of topical 5% imiquimod during pregnancy: a case series.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Animals; Antineoplastic Agents; Condylomata Acuminata; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Pregnancy; Warts | 2006 |
[The relation of local immune status to efficacy of immunotherapy in patients with condyloma acuminatum].
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Female; Genital Diseases, Female; Genital Diseases, Male; HLA-DR Antigens; Humans; Imiquimod; Immunotherapy; Intercellular Adhesion Molecule-1; Lipopolysaccharide Receptors; Male; Middle Aged; Receptors, IgG | 2005 |
[Imiquimod--a substance with a broad working spectrum].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Dermatologic Agents; Focal Epithelial Hyperplasia; Imiquimod; Papillomavirus Infections; Skin Neoplasms | 2004 |
5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; DNA, Viral; Dose-Response Relationship, Drug; Electrocoagulation; Follow-Up Studies; HIV Infections; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Male; Rectal Diseases; Suppositories; Treatment Outcome; Viral Load | 2006 |
A case of severe eczema following use of imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Drug Eruptions; Eczema; Humans; Imiquimod; Male; Ointments; Penile Diseases | 2006 |
TOLLing away in Brazil.
Topics: Adaptor Proteins, Signal Transducing; Aminoquinolines; Animals; Antineoplastic Agents; Antiprotozoal Agents; Brazil; Carcinoma, Basal Cell; Condylomata Acuminata; Diaminopimelic Acid; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation; Gram-Negative Bacteria; Humans; Imiquimod; Immunity, Innate; Infections; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Melanoma; Mice; Models, Immunological; Molecular Structure; Peptidoglycan; Protozoan Infections; Radiation Chimera; RNA Helicases; Signal Transduction; Skin Diseases; Skin Neoplasms; Substrate Specificity; Toll-Like Receptor 7; Toll-Like Receptors | 2006 |
Imiquimod-induced vitiligo in a patient with genital warts.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Penile Diseases; Penis; Vitiligo | 2006 |
[Application of imiquimod and resiquimod in dermatology].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Humans; Imidazoles; Imiquimod; Skin Neoplasms | 2006 |
Immune boosters. Italian study finds immune booster useful against genital warts.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; CD4 Lymphocyte Count; Condylomata Acuminata; Female; HIV Infections; Humans; Imiquimod; Italy; Male; Viral Load | 2004 |
Effectiveness of imiquimod 5% cream for treatment of extensive anogenital warts in a seven-year-old child.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Child; Condylomata Acuminata; Female; Humans; Imiquimod | 2007 |
Imiquimod-induced vitiligo.
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Genital Diseases, Male; Humans; Imiquimod; Male; Risk Assessment; Vitiligo | 2007 |
[Extensive condyloma acuminata of the penis successfully treated with 5% imiquimod cream].
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Male; Penile Diseases; Pharmaceutical Preparations; Remission Induction | 2007 |
Topical imiquimod therapy for external anogenital warts in pregnant women.
Topics: Administration, Cutaneous; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies | 2008 |
Treatment of external genital warts at Planned Parenthood Federation of America centers.
Topics: Adult; Aminoquinolines; Antiviral Agents; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Drug Therapy, Combination; Female; Health Care Costs; Humans; Imiquimod; Male; Treatment Outcome; Trichloroacetic Acid; United States; Voluntary Health Agencies | 2007 |
[Treatment of pediatric genital condyloma].
Topics: Adult; Aminoquinolines; Antiviral Agents; Child; Cidofovir; Condylomata Acuminata; Cytosine; Humans; Imiquimod; Interferon Inducers; Keratinocytes; Organophosphonates; Papillomaviridae; Papillomavirus Infections | 2008 |
Imiquimod for genital warts.
Topics: Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Fees, Pharmaceutical; Female; Humans; Imiquimod; Interferon Inducers; Skin Absorption; Uterine Cervical Neoplasms | 1997 |
New treatments for genital warts less than ideal: abstract and commentary.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Male; Podophyllotoxin | 1998 |
Immune response modification: imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials as Topic; Condylomata Acuminata; Cytokines; Double-Blind Method; Female; Humans; Imiquimod; Immunologic Factors; Interferon Inducers; Interferon-alpha; Male; Papillomaviridae; Placebos; Remission Induction; Viral Load | 1998 |
Imiquimod in clinical practice.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Interferon Inducers; Interferon-alpha; Male; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Recurrence; Remission Induction | 1998 |
The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts.
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Genital Diseases, Female; Genital Diseases, Male; Health Care Costs; Humans; Imiquimod; Interferon Inducers; Male; Medication Systems; Podophyllotoxin; Randomized Controlled Trials as Topic; Self Administration; United States | 1999 |
Recent therapeutic advances in dermatology.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Dermatitis; Dermatology; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Stevens-Johnson Syndrome; Tacrolimus | 2000 |
Management of difficult anogenital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Male; Treatment Outcome | 1999 |
An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts.
Topics: Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Female; Humans; Imiquimod; Male; Medical Audit; Middle Aged; Treatment Outcome | 2000 |
Imiquimod: an immune response modifier.
Topics: Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Immunologic Factors; Interferon Inducers; Virus Replication; Warts | 2000 |
Immunomodulatory therapy in the management of viral infections in patients with HIV infection.
Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Alitretinoin; Aminoquinolines; Antiviral Agents; Condylomata Acuminata; Gels; Humans; Imiquimod; Molluscum Contagiosum; Skin Diseases, Viral; Tretinoin | 2000 |
European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.
Topics: Adjuvants, Immunologic; Algorithms; Aminoquinolines; Caustics; Condylomata Acuminata; Diagnosis, Differential; Family Practice; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Male; Papillomaviridae; Referral and Consultation; Trichloroacetic Acid | 2000 |
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Carcinoma in Situ; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Self Administration; Tumor Virus Infections; Vulvar Neoplasms | 2000 |
Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antigen-Presenting Cells; Bowen's Disease; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Dermis; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Failure | 2001 |
[Proven and promising for the future].
Topics: Aminoquinolines; Anus Diseases; Clinical Trials as Topic; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Ointments; Recurrence; Time Factors | 2001 |
FDA approval of imiquimod cream in treatment of STD warts.
Topics: Administration, Topical; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Rectal Diseases | 1997 |
Genital warts reduced with imiquimod.
Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod | 1998 |
International Congress on Chemotherapy.
Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Aminoquinolines; Anti-Bacterial Agents; Anti-Infective Agents; Antiviral Agents; Condylomata Acuminata; Cryptosporidiosis; Drug Carriers; Exonucleases; Foscarnet; HIV Infections; HIV Protease Inhibitors; Humans; Imiquimod; Liposomes; Roxithromycin | 1995 |
Warts treatment.
Topics: Aminoquinolines; Anal Canal; Antiviral Agents; Condylomata Acuminata; Genitalia; Humans; Imiquimod; Interferon Inducers; Interferon-alpha | 1995 |
Difficult wart cases -- use of imiquimod cream 5%.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Male; Penile Diseases | 2001 |
To cut a long story short - the use of imiquimod in resistant warts.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Drug Resistance; Humans; Imiquimod; Male | 2002 |
Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient.
Topics: Administration, Topical; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Kidney Transplantation; Male; Treatment Outcome | 2002 |
Imiquimod 5% cream in the treatment of anogenital warts in female patients.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Ointments; Recurrence; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2002 |
Imiquimod 5% cream: a topical immune response modifier.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Down-Regulation; Humans; Imiquimod; Immunity, Cellular; Interferon Inducers; Molecular Structure; Randomized Controlled Trials as Topic; Up-Regulation | 2002 |
Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Immunity, Innate; Interferon Inducers; Keratosis; Papillomaviridae; Papillomavirus Infections | 2002 |
Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry.
Topics: Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Bowen's Disease; Condylomata Acuminata; DNA, Viral; Drug Monitoring; Female; Humans; Image Cytometry; Imiquimod; Interferon Inducers; Middle Aged; Papillomaviridae; Skin Neoplasms; Vaginal Neoplasms | 2002 |